“Please be dying, but not too quickly: a clinical trial story” is Bess’s latest essay, and it describes 1. how I got into the petosemtamab clinical trial, which is among the better I could have gotten in; 2. how the process of finding a good clinical trial functions, which is useful for anyone in a position similar to the one Bess and I were in July, and 3. how the clinical trial process can and should be improved. People are dying (I’m one of them) while patients, doctors, and drug companies struggle against a system that appears to have evolved in a dysfunctional direction. We can and should do better.